Twelve-week, randomized, multicenter study comparing a fixed combination of brimonidine-timolol with timolol as therapy adjunctive to latanoprost | Zendy

Robert D. Fechtner | Zendy; Harasymowycz | Zendy; Nixon | Zendy; Vold | Zendy; Zaman | Zendy; David Hollander | Zendy; Williams | Zendy

Open Access

Twelve-week, randomized, multicenter study comparing a fixed combination of brimonidine-timolol with timolol as therapy adjunctive to latanoprost

Author(s) -

Robert D. Fechtner,

Harasymowycz,

Nixon,

Vold,

Zaman,

David Hollander,

Williams

Publication year - 2011

Publication title -

clinical ophthalmology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.025

H-Index - 56

eISSN - 1177-5483

pISSN - 1177-5467

DOI - 10.2147/opth.s19999

Subject(s) - latanoprost , timolol , brimonidine , medicine , intraocular pressure , ophthalmology , ocular hypertension , glaucoma , randomized controlled trial , dorzolamide , adverse effect , anesthesia

To evaluate the additive intraocular pressure (IOP)-lowering efficacy and safety of fixed-combination brimonidine 0.2%/timolol 0.5% compared with timolol 0.5% at peak and trough effect when used as therapy adjunctive to latanoprost 0.005% in patients with glaucoma or ocular hypertension who require additional IOP lowering.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research